Abstract:Promoter hypermethylation is an alternative mechanism of gene silencing in human cancers including gastric cancer. To date, several reports on methylation of various genes in gastric cancer have been published. However, most of these studies have focused on cancer tissues or only a single gene. In this study, we determined the methylation frequency of 5 genes, including p16, Runx3, MGMT, DAPK, and RASSF1A, by methylation-specific polymerase chain reaction, in a series of formalin-fixed paraffin-embedded tissues including normal gastric mucosa (n = 20), intestinal metaplasia (n = 14), gastric epithelial dysplasia (n = 27), and early gastric adenocarcinoma (n = 16). Immunohistochemistry was used to determine expression of MGMT and RASSF1A protein. All 20 histologically normal gastric biopsy specimens were methylation-free for all 5 genes. Aberrant hypermethylation of RASSF1A was not detected in any case from intestinal metaplasia to early gastric adenocarcinoma. The methylation rate of the other 4 genes increased with the histological progression from intestinal metaplasia to gastric epithelial dysplasia, to early gastric adenocarcinoma. Methylation was detected in 28.6% of intestinal metaplasia (4/14), in 77.8% of gastric epithelial dysplasia (21/27), and in 87.5% of early gastric adenocarcinoma (14/16). The average number of methylated genes in intestinal metaplasia, gastric epithelial dysplasia, and early gastric adenocarcinoma was 0.43, 1.3, and 1.8, respectively. Concurrent methylation in 3 or more genes was found in 7.1% of intestinal metaplasia, 11.1% of gastric epithelial dysplasia, and 31.3% of early gastric adenocarcinoma. No correlation was found between hypermethylation and other clinicopathologic parameters such as age, sex, Helicobacter pylori infection, and location of lesions. However, we observed a significant association between hypermethylation of p16 and MGMT and elevated serum carcinoembryonic antigen level. No reduction or loss of RASSF1A expression was observed in our study. Weak or loss of MGMT expression was found in 20 lesions and was significantly associated with promoter hypermethylation (P < .01). Our results suggest that promoter hypermethylation of the p16, Runx3, MGMT, and DAPK genes may play an important role in the pathogenesis of gastric precancerous lesions and early gastric adenocarcinoma. Hypermethylation and inactivation of RASSF1A, however, could be a later event in malignant transformation. Further studies are warranted to determine whether the presence of promoter hypermethylation in gastric precancerous lesions is associated with higher risk of subsequent cancer development and how to interrupt the malignant transition from intestinal metaplasia and gastric epithelial dysplasia to early gastric adenocarcinoma by developing some gene-targeting therapies that may reverse aberrant methylation.

Silencing-specific Methylation and Single Nucleotide Polymorphism of Hmlh1 Promoter in Gastric Carcinomas.

Hypermethylation of CpG island at the hMLHl gene promoter in gastric carcinomas

Hypermethylation Of The Hmlh1 Gene Promoter In Human Gastric Cancers With Microsatellite Instability

Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and Its Use As a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis

Silence of HIN-1 Expression Through Methylation of Its Gene Promoter in Gastric Cancer

Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma

Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions.

Distinct methylation pattern and microsatellite instability in sporadic gastric cancer

Methylation Ofgata-4Andgata-5and Development of Sporadic Gastric Carcinomas

Hypermethylation of Hmlh1 and Microsatellite Instability in Ovarian Mucinous Tumors

Germline promoter hypermethylation of tumor suppressor genes in gastric cancer

Haploinsufficiency by minute MutL homolog 1 promoter DNA methylation may represent unique phenotypes of microsatellite instability-gastric carcinogenesis

Methylation Variable Position Profiles of Hmlh1 Promoter CpG Islands in Human Sporadic Colorectal Carcinoma.

Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines

Connexin 32 and 43 Promoter Methylation in Helicobacter Pylori-Associated Gastric Tumorigenesis

[Cpg Island Methylation of E-cadherin Gene Promoter in Gastric Carcinoma].

Hypermethylation of Multiple Tumor-Related Genes in Gastric Carcinoma and Adjacent Normal Tissues

Hypermethylation Oftgf-Β1gene Promoter in Gastric Cancer

Dna Methylation Markers As Predictors Of Initiation And Progression Of Gastric Carcinomas

Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

Methylation Status of Individual CpG Sites Within Alu Elements in the Human Genome and Alu Hypomethylation in Gastric Carcinomas